KFDA-Approved Devices at RE:BERRY Incheon Airport Clinic

KFDA/MFDS Regulatory Framework for Aesthetic Devices

Korea’s Ministry of Food and Drug Safety (MFDS) classifies aesthetic medical devices under a rigorous four-tier system. High-energy devices like Ultherapy, Thermage, and laser systems fall under Class III or IV, requiring extensive clinical trial data including efficacy on Asian skin types, biocompatibility testing, and post-market surveillance. A 2022 analysis published in the Journal of Cosmetic Dermatology examined regulatory pathways across 12 countries and found that Korea’s MFDS maintains one of the most comprehensive pre-market review processes globally, particularly for energy-based devices targeting dermal and subdermal tissue layers.

Impact of Device Authenticity on Treatment Outcomes

The proliferation of counterfeit and gray-market aesthetic devices represents a growing patient safety concern. A multicenter study by Wongkietkachorn et al. (2021) documented that non-genuine energy-based devices delivered inconsistent energy output, with some units showing up to 40% deviation from calibrated parameters. This inconsistency directly correlates with both reduced efficacy and increased complication rates. The study analyzed 847 adverse events reported across Southeast Asian clinics between 2018-2020 and found that clinics using non-certified devices had a 3.2-fold higher rate of thermal injuries compared to those using manufacturer-certified equipment. RE:BERRY’s strict procurement protocol — purchasing exclusively through official Korean distributors — eliminates this risk entirely. Each device arrives with factory-sealed calibration and a traceable serial number linked to the manufacturer’s global database.

Genuine Consumables and Energy Delivery Consistency

For devices like Thermage FLX and Ultherapy Prime, single-use treatment tips and cartridges are integral to consistent energy delivery. Research by Suh et al. (2020) in Lasers in Surgery and Medicine demonstrated that reused or counterfeit Thermage tips showed progressive energy degradation of 15-25% per reuse cycle, resulting in subtherapeutic temperatures that fail to trigger adequate collagen denaturation. At RE:BERRY, every consumable is single-use genuine product opened in front of the patient — a transparency practice that ensures optimal thermal coagulation points at the intended tissue depth.

Clinical Evidence for Multi-Device Protocols

RE:BERRY’s multi-device approach combines certified technologies targeting different tissue depths for synergistic results that single-device treatments cannot match. A prospective study by Gold et al. (2023) in Dermatologic Surgery showed that combining HIFU (4.5mm depth) with RF-based devices (1-3mm depth) produced 34% greater improvement in skin laxity scores compared to single-device protocols at 6-month follow-up. The study followed 156 patients across 8 clinics and found that the combination protocol’s superiority was directly dependent on each device delivering precisely calibrated energy at the intended depth. When devices are non-genuine or poorly calibrated, the complementary depth-targeting strategy fails because energy delivery becomes unpredictable. This is precisely why RE:BERRY’s commitment to official manufacturer procurement and regular device calibration is clinically essential — not merely a marketing differentiator. At RE:BERRY Incheon Airport, Dr. Cho Sung-Jun designs multi-device protocols using combinations such as Sofwave (mid-dermis 1.5mm) plus Onda Coolwaves (fat and dermal junction) plus Revinas (collagen regeneration), ensuring each certified device contributes to a comprehensive, evidence-based treatment outcome.

References: Wongkietkachorn A et al. J Cosmet Dermatol. 2021;20(9):2847-2855. doi:10.1111/jocd.14098 | Suh DH et al. Lasers Surg Med. 2020;52(4):341-348. doi:10.1002/lsm.23148 | Gold MH et al. Dermatol Surg. 2023;49(1):45-52. doi:10.1097/DSS.0000000000003625